These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8495416)

  • 41. In vitro and in vivo growth suppression of MCF-7 human breast cancer by novel photoproducts and tamoxifen.
    Gulliya KS; Sharma RK; Matthews JL; Benniston AC; Harriman A; Nemunaitis JJ
    Cancer; 1994 Sep; 74(6):1725-32. PubMed ID: 8082074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors.
    Yue W; Brodie A
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):671-3. PubMed ID: 8476781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
    Núñez NP; Jelovac D; Macedo L; Berrigan D; Perkins SN; Hursting SD; Barrett JC; Brodie A
    Clin Cancer Res; 2004 Aug; 10(16):5375-80. PubMed ID: 15328175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
    Gökmen-Polar Y; Toroni RA; Hocevar BA; Badve S; Zhao Q; Shen C; Bruckheimer E; Kinch MS; Miller KD
    Breast Cancer Res Treat; 2011 Jun; 127(2):375-84. PubMed ID: 20602165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents.
    Magarian RA; Avor KS; Overacre LB; Kunchandy J; Paxton TR
    Anticancer Drug Des; 1995 Jun; 10(4):311-31. PubMed ID: 7786397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer.
    Brodie A; Lu Q; Liu Y; Long B; Wang JP; Yue W
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):36-40. PubMed ID: 9556790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
    Kuramoto M; Yamashita J; Ogawa M
    Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effects of 22-oxa-calcitriol and all- trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo.
    Barroga EF; Kadosawa T; Okumura M; Fujinaga T
    Res Vet Sci; 2000 Feb; 68(1):79-87. PubMed ID: 10684763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interrelationship between estradiol and tamoxifen responses for clinical breast carcinoma cells cultured on contact-sensitive plates.
    Matsuoka H; Nakamura Y; Ueo H; Sugimachi K; Tomoda H; Saito T; Seo Y
    Jpn J Cancer Res; 1994 Jun; 85(6):619-25. PubMed ID: 8063615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors.
    Sabet SJ; Darjatmoko SR; Lindstrom MJ; Albert DM
    Arch Ophthalmol; 1999 Mar; 117(3):365-70. PubMed ID: 10088815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice.
    El Etreby MF; Liang Y
    Breast Cancer Res Treat; 1998 May; 49(2):109-17. PubMed ID: 9696393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antitumor effect of triphenylethylene derivative (TAT-59) against human breast carcinoma xenografts in nude mice.
    Koh J; Kubota T; Asanuma F; Yamada Y; Kawamura E; Hosoda Y; Hashimoto M; Yamamoto O; Sakai S; Maeda K
    J Surg Oncol; 1992 Dec; 51(4):254-8. PubMed ID: 1434657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic mice.
    Iino Y; Takai Y; Ando T; Ohwada S; Yokoe T; Sugamata N; Takei H; Horiguchi J; Iijima K; Morishita Y
    Cancer Chemother Pharmacol; 1994; 34(5):372-6. PubMed ID: 8070003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell lines.
    Ellis CA; Vos MD; Wickline M; Riley C; Vallecorsa T; Telford WG; Zujewskil J; Clark GJ
    Breast Cancer Res Treat; 2003 Mar; 78(1):59-67. PubMed ID: 12611458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors.
    Toko T; Sugimoto Y; Matsuo K; Yamasaki R; Takeda S; Wierzba K; Asao T; Yamada Y
    Eur J Cancer; 1990 Mar; 26(3):397-404. PubMed ID: 2141500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.